SID 2026Abstract 0513
The use of topical roflumilast in the treatment of localized, steroid-refractory cutaneous immune-related adverse events
A single-institution real-life study
Block BR, Mehta J, Karpoff K, Verma H, Young J, Gulati N
SID Annual Meeting 2026Chicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Drug reactions
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.544 · Not in PubMed: details from Crossref